help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewis, G. F.
Right arrow Articles by Giacca, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewis, G. F.
Right arrow Articles by Giacca, A.
Endocrine Reviews 23 (2): 201-229
Copyright © 2002 by The Endocrine Society

Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

Gary F. Lewis, André Carpentier, Khosrow Adeli and Adria Giacca

Department of Medicine, Division of Endocrinology (G.F.L., A.C., A.G.), Department of Physiology (A.G.), and Department of Laboratory Medicine and Pathobiology (K.A.), University of Toronto, Toronto, Canada M5G 2C4

Correspondence: Address all correspondence and requests for reprints to: Dr. Gary Lewis, Toronto General Hospital, 200 Elizabeth Street, Room EN11-229, Toronto, Ontario, Canada M5G 2C4. E-mail: gary.lewis{at}uhn.on.ca

The primary genetic, environmental, and metabolic factors responsible for causing insulin resistance and pancreatic ß-cell failure and the precise sequence of events leading to the development of type 2 diabetes are not yet fully understood. Abnormalities of triglyceride storage and lipolysis in insulin-sensitive tissues are an early manifestation of conditions characterized by insulin resistance and are detectable before the development of postprandial or fasting hyperglycemia. Increased free fatty acid (FFA) flux from adipose tissue to nonadipose tissue, resulting from abnormalities of fat metabolism, participates in and amplifies many of the fundamental metabolic derangements that are characteristic of the insulin resistance syndrome and type 2 diabetes. It is also likely to play an important role in the progression from normal glucose tolerance to fasting hyperglycemia and conversion to frank type 2 diabetes in insulin resistant individuals. Adverse metabolic consequences of increased FFA flux, to be discussed in this review, are extremely wide ranging and include, but are not limited to: 1) dyslipidemia and hepatic steatosis, 2) impaired glucose metabolism and insulin sensitivity in muscle and liver, 3) diminished insulin clearance, aggravating peripheral tissue hyperinsulinemia, and 4) impaired pancreatic ß-cell function. The precise biochemical mechanisms whereby fatty acids and cytosolic triglycerides exert their effects remain poorly understood. Recent studies, however, suggest that the sequence of events may be the following: in states of positive net energy balance, triglyceride accumulation in "fat-buffering" adipose tissue is limited by the development of adipose tissue insulin resistance. This results in diversion of energy substrates to nonadipose tissue, which in turn leads to a complex array of metabolic abnormalities characteristic of insulin-resistant states and type 2 diabetes. Recent evidence suggests that some of the biochemical mechanisms whereby glucose and fat exert adverse effects in insulin-sensitive and insulin-producing tissues are shared, thus implicating a diabetogenic role for energy excess as a whole. Although there is now evidence that weight loss through reduction of caloric intake and increase in physical activity can prevent the development of diabetes, it remains an open question as to whether specific modulation of fat metabolism will result in improvement in some or all of the above metabolic derangements or will prevent progression from insulin resistance syndrome to type 2 diabetes.




This article has been cited by other articles:


Home page
 Nutr Clin PractHome page
R. Ness-Abramof and C. M. Apovian
Waist Circumference Measurement in Clinical Practice
Nutr Clin Pract, August 1, 2008; 23(4): 397 - 404.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Yue, J. W. Christman, and T. Mazzone
Tumor Necrosis Factor-{alpha}-Mediated Suppression of Adipocyte Apolipoprotein E Gene Transcription: Primary Role for the Nuclear Factor (NF)-{kappa}B Pathway and NF{kappa}B p50
Endocrinology, August 1, 2008; 149(8): 4051 - 4058.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Rigazio, H.-R. Lehto, H. Tuunanen, K. Nagren, M. Kankaanpaa, C. Simi, R. Borra, A. G. Naum, R. Parkkola, J. Knuuti, et al.
The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans
Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E413 - E419.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
O. Johnston, C. L. Rose, A. C. Webster, and J. S. Gill
Sirolimus Is Associated with New-Onset Diabetes in Kidney Transplant Recipients
J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1411 - 1418.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Wolfrum, J. J. Howell, E. Ndungo, and M. Stoffel
Foxa2 Activity Increases Plasma High Density Lipoprotein Levels by Regulating Apolipoprotein M
J. Biol. Chem., June 13, 2008; 283(24): 16940 - 16949.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Puri, S. Ranjit, S. Konda, S. M. C. Nicoloro, J. Straubhaar, A. Chawla, M. Chouinard, C. Lin, A. Burkart, S. Corvera, et al.
Cidea is associated with lipid droplets and insulin sensitivity in humans
PNAS, June 3, 2008; 105(22): 7833 - 7838.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Duez, B. Lamarche, R. Valero, M. Pavlic, S. Proctor, C. Xiao, L. Szeto, B. W. Patterson, and G. F. Lewis
Both Intestinal and Hepatic Lipoprotein Production Are Stimulated by an Acute Elevation of Plasma Free Fatty Acids in Humans
Circulation, May 6, 2008; 117(18): 2369 - 2376.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. W. Yeckel, J. Dziura, and L. DiPietro
Abdominal Obesity in Older Women: Potential Role for Disrupted Fatty Acid Reesterification in Insulin Resistance
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1285 - 1291.
[Abstract] [Full Text] [PDF]

Home page
 J DAIRY SCIHome page
J. A. A. Pires, J. B. Pescara, A. E. Brickner, N. Silva del Rio, A. P. Cunha, and R. R. Grummer
Effects of Abomasal Infusion of Linseed Oil on Responses to Glucose and Insulin in Holstein Cows
J Dairy Sci, April 1, 2008; 91(4): 1378 - 1390.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. R. Sheets, P. Fulop, Z. Derdak, A. Kassai, E. Sabo, N. M. Mark, G. Paragh, J. R. Wands, and G. Baffy
Uncoupling protein-2 modulates the lipid metabolic response to fasting in mice
Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G1017 - G1024.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Brassard, F. Frisch, F. Lavoie, D. Cyr, A. Bourbonnais, S. C. Cunnane, B. W. Patterson, R. Drouin, J.-P. Baillargeon, and A. C. Carpentier
Impaired Plasma Nonesterified Fatty Acid Tolerance Is an Early Defect in the Natural History of Type 2 Diabetes
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 837 - 844.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. A. Kostiuk, M. M. Corvi, B. O. Keller, G. Plummer, J. A. Prescher, M. J. Hangauer, C. R. Bertozzi, G. Rajaiah, J. R. Falck, and L. G. Berthiaume
Identification of palmitoylated mitochondrial proteins using a bio-orthogonal azido-palmitate analogue
FASEB J, March 1, 2008; 22(3): 721 - 732.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. I. Oprescu, G. Bikopoulos, A. Naassan, E. M. Allister, C. Tang, E. Park, H. Uchino, G. F. Lewis, I. G. Fantus, M. Rozakis-Adcock, et al.
Free Fatty Acid Induced Reduction in Glucose-Stimulated Insulin Secretion: Evidence for a Role of Oxidative Stress In Vitro and In Vivo
Diabetes, December 1, 2007; 56(12): 2927 - 2937.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Kotronen, S. Vehkavaara, A. Seppala-Lindroos, R. Bergholm, and H. Yki-Jarvinen
Effect of liver fat on insulin clearance
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1709 - E1715.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J.-H. Hwang, D. T. Stein, N. Barzilai, M.-H. Cui, J. Tonelli, P. Kishore, and M. Hawkins
Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1663 - E1669.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. Roberge, A. C. Carpentier, M.-F. Langlois, J.-P. Baillargeon, J.-L. Ardilouze, P. Maheux, and N. Gallo-Payet
Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1465 - E1478.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Hessel, A. Eichinger, A. Isken, J. Amengual, S. Hunzelmann, U. Hoeller, V. Elste, W. Hunziker, R. Goralczyk, V. Oberhauser, et al.
CMO1 Deficiency Abolishes Vitamin A Production from beta-Carotene and Alters Lipid Metabolism in Mice
J. Biol. Chem., November 16, 2007; 282(46): 33553 - 33561.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. Hodson, A. S.T. Bickerton, S. E. McQuaid, R. Roberts, F. Karpe, K. N. Frayn, and B. A. Fielding
The Contribution of Splanchnic Fat to VLDL Triglyceride Is Greater in Insulin-Resistant Than Insulin-Sensitive Men and Women: Studies in the Postprandial State
Diabetes, October 1, 2007; 56(10): 2433 - 2441.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
M. Kumazawa, M. Kobayashi, F. Io, T. Kawai, M. Nishimura, T. Ohno, and F. Horio
Searching for genetic factors of fatty liver in SMXA-5 mice by quantitative trait loci analysis under a high-fat diet
J. Lipid Res., September 1, 2007; 48(9): 2039 - 2046.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J. L Kuk, P. M Janiszewski, and R. Ross
Body mass index and hip and thigh circumferences are negatively associated with visceral adipose tissue after control for waist circumference
Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1540 - 1544.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
J.-C. Hogue, B. Lamarche, A. J. Tremblay, J. Bergeron, C. Gagne, and P. Couture
Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes
J. Lipid Res., June 1, 2007; 48(6): 1336 - 1342.
[Abstract] [Full Text] [PDF]

Home page
 J DAIRY SCIHome page
J. A. A. Pires, A. H. Souza, and R. R. Grummer
Induction of Hyperlipidemia by Intravenous Infusion of Tallow Emulsion Causes Insulin Resistance in Holstein Cows
J Dairy Sci, June 1, 2007; 90(6): 2735 - 2744.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H.-Y. Liu, Q. F. Collins, Y. Xiong, F. Moukdar, E. G. Lupo Jr., Z. Liu, and W. Cao
Prolonged Treatment of Primary Hepatocytes with Oleate Induces Insulin Resistance through p38 Mitogen-activated Protein Kinase
J. Biol. Chem., May 11, 2007; 282(19): 14205 - 14212.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Wei, W. Gao, and R. Lehner
Attenuation of Adipocyte Triacylglycerol Hydrolase Activity Decreases Basal Fatty Acid Efflux
J. Biol. Chem., March 16, 2007; 282(11): 8027 - 8035.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
G. Perseghin, G. Lattuada, F. De Cobelli, F. Ragogna, G. Ntali, A. Esposito, E. Belloni, T. Canu, I. Terruzzi, P. Scifo, et al.
Habitual Physical Activity Is Associated With Intrahepatic Fat Content in Humans
Diabetes Care, March 1, 2007; 30(3): 683 - 688.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
M. F. Crutchlow and R. D. Bloom
Transplant-Associated Hyperglycemia: A New Look at an Old Problem
Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 343 - 355.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. C. Carpentier, F. Frisch, P. Brassard, F. Lavoie, A. Bourbonnais, D. Cyr, R. Giguere, and J.-P. Baillargeon
Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E693 - E701.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. Juurinen, M. Tiikkainen, A.-M. Hakkinen, A. Hakkarainen, and H. Yki-Jarvinen
Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E829 - E835.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. M. Sharma and B. Staels
Peroxisome Proliferator-Activated Receptor {gamma} and Adipose Tissue--Understanding Obesity-Related Changes in Regulation of Lipid and Glucose Metabolism
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 386 - 395.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Qu, D. Su, J. Altomonte, A. Kamagate, J. He, G. Perdomo, T. Tse, Y. Jiang, and H. H. Dong
PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1
Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E421 - E434.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. S.T. Bickerton, R. Roberts, B. A. Fielding, L. Hodson, E. E. Blaak, A. J.M. Wagenmakers, M. Gilbert, F. Karpe, and K. N. Frayn
Preferential Uptake of Dietary Fatty Acids in Adipose Tissue and Muscle in the Postprandial Period
Diabetes, January 1, 2007; 56(1): 168 - 176.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
K. Blouin, C. Richard, G. Brochu, F.-S. Hould, S. Lebel, S. Marceau, S. Biron, V. Luu-The, and A. Tchernof
Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men
J. Endocrinol., December 1, 2006; 191(3): 637 - 649.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Q. F. Collins, Y. Xiong, E. G. Lupo Jr., H.-Y. Liu, and W. Cao
p38 Mitogen-activated Protein Kinase Mediates Free Fatty Acid-induced Gluconeogenesis in Hepatocytes
J. Biol. Chem., August 25, 2006; 281(34): 24336 - 24344.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Pagano, C. Pilon, M. Olivieri, P. Mason, R. Fabris, R. Serra, G. Milan, M. Rossato, G. Federspil, and R. Vettor
Reduced Plasma Visfatin/Pre-B Cell Colony-Enhancing Factor in Obesity Is Not Related to Insulin Resistance in Humans
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3165 - 3170.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Z. T. Bloomgarden
Third Annual World Congress on the Insulin Resistance Syndrome: Mediators, antecedents, and measurement
Diabetes Care, July 1, 2006; 29(7): 1700 - 1706.
[Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
V. van Weel, M. de Vries, P. J. Voshol, R. E. Verloop, P. H.C. Eilers, V. W.M. van Hinsbergh, J. H. van Bockel, and P. H.A. Quax
Hypercholesterolemia Reduces Collateral Artery Growth More Dominantly Than Hyperglycemia or Insulin Resistance in Mice
Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1383 - 1390.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
H. Duez, B. Lamarche, K. D. Uffelman, R. Valero, J. S. Cohn, and G. F. Lewis
Hyperinsulinemia Is Associated With Increased Production Rate of Intestinal Apolipoprotein B-48-Containing Lipoproteins in Humans
Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1357 - 1363.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
H. Yoshii, T. K. T. Lam, N. Gupta, T. Goh, C. A. Haber, H. Uchino, T. T. Y. Kim, V. Z. Chong, K. Shah, I. G. Fantus, et al.
Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux
Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1089 - E1097.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Beha, H.-P. Juretschke, J. Kuhlmann, C. Neumann-Haefelin, U. Belz, M. Gerl, W. Kramer, M. Roden, and A. W. Herling
Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E989 - E997.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
B. Desvergne, L. Michalik, and W. Wahli
Transcriptional Regulation of Metabolism
Physiol Rev, April 1, 2006; 86(2): 465 - 514.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Dimitriadis, P. Mitrou, V. Lambadiari, E. Boutati, E. Maratou, E. Koukkou, M. Tzanela, N. Thalassinos, and S. A. Raptis
Glucose and Lipid Fluxes in the Adipose Tissue after Meal Ingestion in Hyperthyroidism
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1112 - 1118.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
H. Wang, L. A. Reaves, and N. K. Edens
Ginseng Extract Inhibits Lipolysis in Rat Adipocytes In Vitro by Activating Phosphodiesterase 4
J. Nutr., February 1, 2006; 136(2): 337 - 342.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T. Pulinilkunnil and B. Rodrigues
Cardiac lipoprotein lipase: Metabolic basis for diabetic heart disease
Cardiovasc Res, February 1, 2006; 69(2): 329 - 340.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
H. S. Kahn
The Lipid Accumulation Product Is Better Than BMI for Identifying Diabetes: A population-based comparison
Diabetes Care, January 1, 2006; 29(1): 151 - 153.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. D. Monti, E. Setola, G. Fragasso, R. P. Camisasca, P. Lucotti, E. Galluccio, A. Origgi, A. Margonato, and P. Piatti
Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E54 - E59.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
M. Hamaguchi, T. Kojima, N. Takeda, T. Nakagawa, H. Taniguchi, K. Fujii, T. Omatsu, T. Nakajima, H. Sarui, M. Shimazaki, et al.
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Ann Intern Med, November 15, 2005; 143(10): 722 - 728.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. Larbi, A. Grenier, F. Frisch, N. Douziech, C. Fortin, A. C Carpentier, and T. Fulop
Acute in vivo elevation of intravascular triacylglycerol lipolysis impairs peripheral T cell activation in humans
Am. J. Clinical Nutrition, November 1, 2005; 82(5): 949 - 956.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
Ghafoorunissa, A. Ibrahim, L. Rajkumar, and V. Acharya
Dietary (n-3) Long Chain Polyunsaturated Fatty Acids Prevent Sucrose-Induced Insulin Resistance in Rats
J. Nutr., November 1, 2005; 135(11): 2634 - 2638.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. C. Carpentier, F. Frisch, D. Cyr, P. Genereux, B. W. Patterson, R. Giguere, and J.-P. Baillargeon
On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans
Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E849 - E856.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. Teutonico, P. F. Schena, and S. Di Paolo
Glucose Metabolism in Renal Transplant Recipients: Effect of Calcineurin Inhibitor Withdrawal and Conversion to Sirolimus
J. Am. Soc. Nephrol., October 1, 2005; 16(10): 3128 - 3135.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. R. Van Gilst, H. Hadjivassiliou, and K. R. Yamamoto
From The Cover: A Caenorhabditis elegans nutrient response system partially dependent on nuclear receptor NHR-49
PNAS, September 20, 2005; 102(38): 13496 - 13501.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Adiels, J. Boren, M. J. Caslake, P. Stewart, A. Soro, J. Westerbacka, B. Wennberg, S.-O. Olofsson, C. Packard, and M.-R. Taskinen
Overproduction of VLDL1 Driven by Hyperglycemia Is a Dominant Feature of Diabetic Dyslipidemia
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1697 - 1703.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J. B Ruige, D. P Ballaux, T. Funahashi, I. L Mertens, Y. Matsuzawa, and L. F Van Gaal
Resting metabolic rate is an important predictor of serum adiponectin concentrations: potential implications for obesity-related disorders
Am. J. Clinical Nutrition, July 1, 2005; 82(1): 21 - 25.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
N. Saravanan, A. Haseeb, N. Z Ehtesham, and Ghafoorunissa
Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue
Eur. J. Endocrinol., July 1, 2005; 153(1): 159 - 165.
[Abstract] [Full Text] [PDF]

Home page
 Clin. DiabetesHome page
E. H. Harris
Elevated Liver Function Tests in Type 2 Diabetes
Clin. Diabetes, July 1, 2005; 23(3): 115 - 119.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Charbonneau, A. Melancon, C. Lavoie, and J.-M. Lavoie
Alterations in hepatic glucagon receptor density and in Gs{alpha} and Gi{alpha}2 protein content with diet-induced hepatic steatosis: effects of acute exercise
Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E8 - E14.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
B.-S. Cha, T. P. Ciaraldi, K.-S. Park, L. Carter, S. R. Mudaliar, and R. R. Henry
Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPAR{gamma} agonists
Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E151 - E159.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
G. F. Lewis and D. J. Rader
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Circ. Res., June 24, 2005; 96(12): 1221 - 1232.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
C. Lemieux, Y. Gelinas, J. Lalonde, F. Labrie, K. Cianflone, and Y. Deshaies
Hypolipidemic action of the SERM acolbifene is associated with decreased liver MTP and increased SR-BI and LDL receptors
J. Lipid Res., June 1, 2005; 46(6): 1285 - 1294.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Y. Tamura, Y. Tanaka, F. Sato, J. B. Choi, H. Watada, M. Niwa, J. Kinoshita, A. Ooka, N. Kumashiro, Y. Igarashi, et al.
Effects of Diet and Exercise on Muscle and Liver Intracellular Lipid Contents and Insulin Sensitivity in Type 2 Diab